Bone metastases, general and clinical issues.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  The Quarterly Journal of Nuclear Medicine and Molecular Imaging

• Publication date

  2011-08-01

• Fields of study

  Medicine

• Identifiers
  PMID 21738111
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment Outcome and Prognostic Factors for Patients with Bone-Only Metastases of Breast Cancer: A Single-Institution Retrospective Analysis

  2011cited by this paper
• Zoledronic acid use in cancer patients

  2011cited by this paper
• Comparison of 18F-FDG-PET/CT with 99mTc-MDP bone scintigraphy for the detection of bone metastases in cancer patients

  2010cited by this paper
• Reliability analysis of the epidural spinal cord compression scale.

  2010cited by this paper
• Bisphosphonates as treatment of bone metastases.

  2010cited by this paper
• Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy.

  2010cited by this paper
• The role of radiotherapy for metastatic epidural spinal cord compression

  2010cited by this paper
• Bone morphogenetic proteins and its receptors; therapeutic targets in cancer progression and bone metastasis?

  2010cited by this paper
• Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisited.

  2010cited by this paper
• Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model

  2010cited by this paper
• Bone morphogenetic proteins (BMPs): from morphogens to metabologens.

  2009cited by this paper
• Microenvironmental regulation of metastasis

  2009cited by this paper
• Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer.

  2009cited by this paper
• Imaging metastatic bone disease from carcinoma of the prostate

  2009cited by this paper
• Systems pathology

  2009cited by this paper
• Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers.

  2009cited by this paper
• Cancer-induced hypercalcemia.

  2009cited by this paper
• 8Gy single-dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial.

  2009cited by this paper
• Patterns of Recurrence After Curative-Intent Radiation for Oligometastases Confined to One Organ

  2009cited by this paper
• The tumor microenvironment and its contribution to tumor evolution toward metastasis

  2008cited by this paper
• Metastatic epidural spinal cord compression.

  2008cited by this paper
• Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis.

  2008cited by this paper
• Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: a comparative study

  2008cited by this paper
• International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice?

  2008cited by this paper
• Whole-body magnetic resonance imaging for detecting bone metastases: comparison with bone scintigraphy

  2008cited by this paper
• High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions.

  2008cited by this paper
• Zoledronic acid: a pharmacoeconomic review of its use in the management of bone metastases.

  2008cited by this paper
• Correlation of local failure with measures of dose insufficiency in the high-dose single-fraction treatment of bony metastases.

  2008cited by this paper
• An Initial Report of a Radiation Dose-Escalation Trial in Patients with One to Five Sites of Metastatic Disease

  2008cited by this paper
• Broadening the scope of Image-Guided Radiotherapy (IGRT)

  2008cited by this paper
• Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer

  2007cited by this paper
• Metastasis: recent discoveries and novel treatment strategies.

  2007cited by this paper
• Prospective Evaluation of Samarium-153-EDTMP Radionuclide Treatment for Bone Metastases in Patients with Hormone-Refractory Prostate Cancer

  2007cited by this paper
• Predictors of skeletal complications in men with hormone-refractory metastatic prostate cancer.

  2007cited by this paper
• On the horizon: can bisphosphonates prevent bone metastases?

  2007cited by this paper
• Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model.

  2007cited by this paper
• Prevalence of osteoporosis during long-term androgen deprivation therapy in patients with prostate cancer.

  2007cited by this paper
• A REVIEW OF IMAGE‐GUIDED INTENSITY‐MODULATED RADIOTHERAPY FOR SPINAL TUMORS

  2007cited by this paper
• Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.

  2007cited by this paper
• Detection of bone metastases: assessment of integrated FDG PET/CT imaging.

  2007cited by this paper
• Combination ibandronate and radiotherapy for the treatment of bone metastases: clinical evaluation and radiologic assessment.

  2007cited by this paper
• Palliative radiotherapy trials for bone metastases: a systematic review.

  2007cited by this paper
• A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal-cord compression treated by radiotherapy: TROG 01.05 Superdex study.

  2006cited by this paper
• Biology of Bone Cancer Pain

  2006cited by this paper
• Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene.

  2006cited by this paper
• Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity

  2006cited by this paper
• Genes associated with breast cancer metastatic to bone.

  2006cited by this paper
• Metastatic epidural spinal cord compression: update on management.

  2006cited by this paper
• Radiation Treatment Decreases Bone Cancer Pain through Direct Effect on Tumor Cells

  2005cited by this paper
• Comparison of 1 x 8 Gy and 10 x 3 Gy for functional outcome in patients with metastatic spinal cord compression.

  2005cited by this paper
• Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial.

  2005cited by this paper
• Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.

  2005cited by this paper
• Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.

  2005cited by this paper
• The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer.

  2005cited by this paper
• Long‐term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors

  2004cited by this paper
• Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases.

  2003cited by this paper
• Mechanisms of Tumor Metastasis to the Bone: Challenges and Opportunities

  2003cited by this paper
• Bone resorption predicts for skeletal complications in metastatic bone disease

  2003cited by this paper
• A multigenic program mediating breast cancer metastasis to bone.

  2003cited by this paper
• A molecular signature of metastasis in primary solid tumors

  2003cited by this paper
• Simple radiographic parameter predicts fracturing in metastatic femoral bone lesions: results from a randomised trial.

  2003cited by this paper
• Bone cancer pain

  2003cited by this paper
• A population-based study of malignant spinal cord compression in Ontario.

  2003cited by this paper
• Bone markers in the management of patients with skeletal metastases

  2003cited by this paper
• Final results of a prospective study of the prognostic value of the time to develop motor deficits before irradiation in metastatic spinal cord compression.

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy--a systematic review of randomised trials.

  2002cited by this paper
• Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma

  2001cited by this paper
• Factors influencing visualization of vertebral metastases on MR imaging versus bone scintigraphy.

  2001cited by this paper
• Radiological imaging for the diagnosis of bone metastases.

  2001cited by this paper
• Metastatic bone disease: clinical features, pathophysiology and treatment strategies.

  2001cited by this paper
• Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.

  2001cited by this paper
• Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients.

  2000cited by this paper
• Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity.

  2000cited by this paper
• Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases

  2000cited by this paper
• The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study.

  1999cited by this paper
• [Remineralization and pain relief in bone metastases after after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study].

  1999cited by this paper
• A phase I/II study to evaluate the effect of fractionated hemibody irradiation in the treatment of osseous metastases--RTOG 88-22.

  1996cited by this paper
• Oligometastases.

  1995cited by this paper
• Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial.

  1994cited by this paper
• Comparison of radionuclide bone scans and magnetic resonance imaging in detecting spinal metastases.

  1993cited by this paper
• High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression

  1992cited by this paper
• Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer.

  1991cited by this paper
• A dose-response study of dexamethasone in a model of spinal cord compression caused by epidural tumor.

  1989cited by this paper
• Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression

  1989cited by this paper
• The palliation of symptomatic osseous metastases final results of the study by the radiation therapy oncology group

  1982cited by this paper
• Effects of radiation therapy on bone lesions as measured by 47 Ca and 85 Sr local kinetics.

  1972cited by this paper

• Synergistic effect between denosumab and immune checkpoint inhibitors (ICI)? A retrospective study of 268 patients with ICI and bone metastases

  2024cites this paper
• The new bone WB-SPECT/CT: hybrid, from head-to-toe and digital! Is it worth the effort?

  2023cites this paper
• Spinal brachytherapy.

  2022cites this paper
• Iodine-125 radioactive seed brachytherapy as a treatment for spine and bone metastases: A systematic review and meta-analysis.

  2021cites this paper
• RNF219/α‐Catenin/LGALS3 Axis Promotes Hepatocellular Carcinoma Bone Metastasis and Associated Skeletal Complications

  2020cites this paper
• Clinical utility of 188Rhenium-hydroxyethylidene-1,1-diphosphonate as a bone pain palliative in multiple malignancies

  2018cites this paper
• Radiochemical studies, pre-clinical investigation and preliminary clinical evaluation of 170Tm-EDTMP prepared using in-house freeze-dried EDTMP kit.

  2017cites this paper
• Radiopharmaceuticals for metastatic bone pain palliation: available options in the clinical domain and their comparisons

  2016cites this paper
• Effects of low-dose capecitabine on Samarium-153-EDTMP therapy for painful bone metastases

  2015cites this paper
• Spinal metastases: From conventional fractionated radiotherapy to single-dose SBRT.

  2015cites this paper
• Malign Akciğer Tümör Metastazına Bağlı Spontan Servikal Vertebral Kırık

  2014influential citation
• Clinical Perspectives: Breast Cancer Bone Metastasis

  2014cites this paper
• The Role of Palliative External Beam Radiation Therapy in Boney Metastases Pain Management

  2013cites this paper
• Bone metastases radiopharmaceuticals: an overview.

  2013cites this paper
• Phase 2 Study of a High Dose of 186Re-HEDP for Bone Pain Palliation in Patients with Widespread Skeletal Metastases

  2013cites this paper
• Spinal metastasis subjected to photodynamic therapy: an update

  2012cites this paper
• Protocolo terapéutico de la hipercalcemia

  2012cites this paper
• TGF-β signalling and its role in cancer progression and metastasis

  2012cites this paper
• PET Tracer F-18-Fluciclovine Can Detect Histologically Proven Bone Metastatic Lesions: A Preclinical Study in Rat Osteolytic and Osteoblastic Bone Metastasis Models

  year unknowncites this paper